
Portrai leverages cutting-edge spatial transcriptomics to reveal unprecedented biological insights, transforming target discovery into transformative therapies. They partner globally with biopharma innovators, combining their spatial biology expertise to co-develop next-generation therapies. Their platform highlights include a target discovery engine for rapid identification of therapeutic targets and disease indications, spatial insights for understanding pathophysiology and drug distribution to optimize drug candidates, and an AI pathology biomarker engine for developing spatial biomarkers and companion diagnostics to enhance precision medicine and therapeutic efficacy. They possess a spatial database encompassing over 2,000 patient samples and more than 50 million spatially resolved cells.

Portrai leverages cutting-edge spatial transcriptomics to reveal unprecedented biological insights, transforming target discovery into transformative therapies. They partner globally with biopharma innovators, combining their spatial biology expertise to co-develop next-generation therapies. Their platform highlights include a target discovery engine for rapid identification of therapeutic targets and disease indications, spatial insights for understanding pathophysiology and drug distribution to optimize drug candidates, and an AI pathology biomarker engine for developing spatial biomarkers and companion diagnostics to enhance precision medicine and therapeutic efficacy. They possess a spatial database encompassing over 2,000 patient samples and more than 50 million spatially resolved cells.